{"id":29757,"date":"2026-03-06T11:58:01","date_gmt":"2026-03-06T11:58:01","guid":{"rendered":"https:\/\/www.vtmarkets.com\/tr\/uncategorized\/cresco-labs-beklentilere-paralel-olarak-4-ceyrekte-hisse-basina-002-dolar-zarar-acikladi-gelirler-ise-yillik-bazda-tahminleri-asti\/"},"modified":"2026-03-06T11:58:01","modified_gmt":"2026-03-06T11:58:01","slug":"cresco-labs-beklentilere-paralel-olarak-4-ceyrekte-hisse-basina-002-dolar-zarar-acikladi-gelirler-ise-yillik-bazda-tahminleri-asti","status":"publish","type":"post","link":"https:\/\/www.vtmarkets.com\/tr-mena\/live-updates\/cresco-labs-beklentilere-paralel-olarak-4-ceyrekte-hisse-basina-002-dolar-zarar-acikladi-gelirler-ise-yillik-bazda-tahminleri-asti\/","title":{"rendered":"Cresco Labs, beklentilere paralel olarak 4. \u00e7eyrekte hisse ba\u015f\u0131na 0,02 dolar zarar a\u00e7\u0131klad\u0131; gelirler ise y\u0131ll\u0131k bazda tahminleri a\u015ft\u0131"},"content":{"rendered":"Cresco Labs Inc., Aral\u0131k 2025\u2019te sona eren 4. \u00e7eyrekte hisse ba\u015f\u0131na (EPS) d\u00fczeltilmi\u015f (tek seferlik gelir\/giderler ay\u0131kland\u0131ktan sonraki) 0,02 dolar zarar a\u00e7\u0131klad\u0131. Bu rakam, Zacks Konsens\u00fcs Tahmini ile ayn\u0131. \u015eirket ge\u00e7en y\u0131l\u0131n ayn\u0131 d\u00f6neminde hisse ba\u015f\u0131na 0,01 dolar d\u00fczeltilmi\u015f zarar a\u00e7\u0131klam\u0131\u015ft\u0131.\n\nA\u00e7\u0131klanan sonu\u00e7larda k\u00e2r s\u00fcrprizi (beklentiye g\u00f6re sapma) +%14,16 oldu. Bir \u00f6nceki \u00e7eyrekte piyasa hisse ba\u015f\u0131na 0,03 dolar zarar beklerken, \u015firket 0,05 dolar zarar a\u00e7\u0131klam\u0131\u015f ve -%66,67 s\u00fcrpriz yapm\u0131\u015ft\u0131.\n\n\u00c7eyreklik gelir 161,55 milyon dolar ile konsens\u00fcs tahminini %0,26 a\u015ft\u0131. Bu, ge\u00e7en y\u0131lki 175,91 milyon dolara k\u0131yasla daha d\u00fc\u015f\u00fck bir seviye. \u015eirket son d\u00f6rt \u00e7eyre\u011fin \u00fc\u00e7\u00fcnde gelir tahminlerini a\u015fmay\u0131 ba\u015fard\u0131.\n\nHisse, y\u0131lba\u015f\u0131ndan bu yana yakla\u015f\u0131k %20,7 geriledi; S&#038;P 500 ise ayn\u0131 d\u00f6nemde %0,4 y\u00fckseldi. Hisse Zacks S\u0131ralamas\u0131\u2019nda #4 (Sat) seviyesinde. Medical &#8211; Products (T\u0131bbi \u00dcr\u00fcnler) end\u00fcstrisi de 250+ Zacks end\u00fcstrisi i\u00e7inde alt %45\u2019lik dilimde yer al\u0131yor.\n\nMevcut konsens\u00fcs, gelecek \u00e7eyrekte 162 milyon dolar gelirle hisse ba\u015f\u0131na -0,03 dolar zarar; mali y\u0131l genelinde ise 670,41 milyon dolar gelirle hisse ba\u015f\u0131na -0,09 dolar zarar \u00f6ng\u00f6r\u00fcyor. Myomo, Inc.\u2019in 9 Mart\u2019ta finansal sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klamas\u0131 bekleniyor; beklentiler hisse ba\u015f\u0131na 0,09 dolar zarar (ge\u00e7en y\u0131la g\u00f6re de\u011fi\u015fim: -%800) ve %15,9 d\u00fc\u015f\u00fc\u015fle 10,15 milyon dolar gelir y\u00f6n\u00fcnde.\n\nFederal d\u00fczenleme haberleri (devletin sekt\u00f6r\u00fc hangi kurallara tabi tutaca\u011f\u0131) en b\u00fcy\u00fck belirsizlik olmaya devam ediyor; \u00f6zellikle DEA\u2019n\u0131n \u201cyeniden s\u0131n\u0131fland\u0131rma\u201d s\u00fcreci (esrar\u0131n federal d\u00fczeyde hangi uyu\u015fturucu s\u0131n\u0131f\u0131nda say\u0131laca\u011f\u0131na ili\u015fkin s\u00fcre\u00e7) 2025 boyunca bir\u00e7ok kez gecikti. Bu cepheden beklenmedik olumlu bir a\u00e7\u0131klama, sert bir y\u00fckseli\u015f getirebilir ve tamamen d\u00fc\u015f\u00fc\u015f y\u00f6nl\u00fc pozisyonlar\u0131 zor durumda b\u0131rakabilir. Bu nedenle, s\u0131n\u0131rl\u0131 riskli spread stratejileri (zarar\u0131 ba\u015ftan belirli seviyede s\u0131n\u0131rlayan opsiyon kombinasyonlar\u0131), \u201c\u00e7\u0131plak put\u201d (tek ba\u015f\u0131na put opsiyonu almak) veya hisseyi a\u00e7\u0131\u011fa satmaya k\u0131yasla daha temkinli bir yakla\u015f\u0131m olarak \u00f6ne \u00e7\u0131kar.\n<p>\n\n<p><strong>Hemen i\u015flem yapmaya ba\u015flay\u0131n &#8211; Ger\u00e7ek VT Markets hesab\u0131n\u0131z\u0131 olu\u015fturmak i\u00e7in <a href=\"https:\/\/www.vtmarkets.com\/tr\/trade-now\/\">buraya<\/a> t\u0131klay\u0131n <\/strong> <\/p>\n<!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"<p>Cresco Labs 4\u00c7\u2019te EPS -0,02$ ile beklentiye paralel, gelir 161,6 mn$ ile hafif \u00fcst\u00fc; hisse %20,7 d\u00fc\u015ft\u00fc. Belirsizlik: DEA yeniden s\u0131n\u0131fland\u0131rma. S\u0131n\u0131rl\u0131 riskli spread\u2019ler \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n","protected":false},"author":87,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[71],"tags":[],"class_list":["post-29757","post","type-post","status-publish","format-standard","hentry","category-live-updates"],"acf":{"acf_article_selection_author":null},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts\/29757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/users\/87"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/comments?post=29757"}],"version-history":[{"count":0,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/posts\/29757\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/media?parent=29757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/categories?post=29757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/tr-mena\/wp-json\/wp\/v2\/tags?post=29757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}